The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Prostate
; 69(5): 480-93, 2009 Apr 01.
Article
in En
| MEDLINE
| ID: mdl-19107880
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Hyperplasia
/
Calcitriol
/
Interleukin-8
/
NF-kappa B
/
RhoA GTP-Binding Protein
/
Rho-Associated Kinases
Limits:
Humans
/
Male
Language:
En
Journal:
Prostate
Year:
2009
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States